Investor Information
Stock information
| Shareholder structure | |
|---|---|
| To its knowledge, as of 31 December 2013, Nicox’ capital structure was: | |
| Public | 89,04% |
| Main shareholders | Bpifrance Participations SA (ex FSI) Petrone Group Blombank (Switzerland) – shares held for third parties |
| Founding managers | 1.92% |
| Share capital | € 19,848,329.60 |
| Number of outstanding shares | 99 241 648 |
| Number of voting rights as of February 28, 2015 | 99 241 648
|
| Total number of voting rights calculated on the basis of all the shares to which voting rights are attached even if exercise thereof is suspended | 99 241 648 |
| Eligibility for PEA-PME-ETI (document in French) | |
| Share price | Euronext |
| Analyst coverage: Search based in France | |
| Euroclear France code | 7413 |
| Reuters code | NCOX.PA |
| Bloomberg code | COX.FP |
| NYSE Euronext | CAC Mids & Smalls |
| FTSE Classification | Economical group: non cyclical consumer goods (40) Industrial sector: pharmaceuticals (48) Industry sub-sector: pharmaceuticals (480) |
| Listing Segment | Euronext Paris: Eurolist Next Economy |